Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 257
8
Diseases
12
Unique genes
0.292
Avg. similarity score
Acrodysostosis 1, with or without hormone resistance
Most-connected disease (7 links)
Disease
Searched: Peripheral nerve schwannoma
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Peripheral nerve schwannoma
Acrodysostosis 1, with or without hormone resistance
Atrial myxoma
Primary pigmented nodular adrenocortical disease 1
Acrodysostosis
Melanotic neurilemmoma
Oncocytic neoplasm
Testicular large cell calcifying sertoli cell tumor
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Acrodysostosis 1, with or without hormone resistance | 7 | 7 | 1 |
| Atrial myxoma | 7 | 7 | 1 |
| Primary pigmented nodular adrenocortical disease 1 | 7 | 7 | 1 |
| Acrodysostosis | 4 | 4 | 2 |
| Melanotic neurilemmoma | 4 | 4 | 2 |
| Oncocytic neoplasm | 3 | 3 | 4 |
| Peripheral nerve schwannoma | 3 | 3 | 4 |
| Testicular large cell calcifying sertoli cell tumor | 3 | 3 | 4 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PRKAR1A | 8 / 8 | Acrodysostosis, Acrodysostosis 1, with or without hormone resistance, Atrial myxoma, Melanotic neurilemmoma and 4 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| DARPP-32 events | Reactome | 2 / 19 | 105× | 1.55e-4 | 2.68e-3 ✓ sig. |
| RHO GTPases activate PAKs | Reactome | 2 / 23 | 87.0× | 2.29e-4 | 3.65e-3 ✓ sig. |
| Hippo signaling pathway - multiple species | KEGG | 2 / 29 | 69.0× | 3.66e-4 | 5.24e-3 ✓ sig. |
| Hippo signaling pathway | KEGG | 3 / 157 | 19.1× | 4.42e-4 | 6.06e-3 ✓ sig. |
| Proteoglycans in cancer | KEGG | 3 / 204 | 14.7× | 9.49e-4 | 1.09e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH6 | Reactome | 1 / 2 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH3 | Reactome | 1 / 2 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Bacterial invasion of epithelial cells | KEGG | 2 / 78 | 25.7× | 2.63e-3 | 2.33e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH2 | Reactome | 1 / 3 | 334× | 2.99e-3 | 2.54e-2 ✓ sig. |
| Colorectal cancer | KEGG | 2 / 87 | 23.0× | 3.27e-3 | 2.71e-2 ✓ sig. |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | Reactome | 1 / 5 | 200× | 4.99e-3 | 3.64e-2 ✓ sig. |
| InlB-mediated entry of Listeria monocytogenes into host cell | Reactome | 1 / 7 | 143× | 6.97e-3 | 4.53e-2 ✓ sig. |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | Reactome | 1 / 7 | 143× | 6.97e-3 | 4.53e-2 ✓ sig. |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | Reactome | 1 / 8 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
| RUNX3 regulates WNT signaling | Reactome | 1 / 8 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of cell differentiation | GO:0045597 | 3 / 83 | 56.3× | 1.81e-5 | 8.57e-4 ✓ sig. |
| ectoderm development | GO:0007398 | 2 / 15 | 208× | 3.95e-5 | 1.54e-3 ✓ sig. |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 / 21 | 148× | 7.88e-5 | 2.60e-3 ✓ sig. |
| negative regulation of cAMP/PKA signal transduction | GO:0141162 | 2 / 28 | 111× | 1.42e-4 | 3.97e-3 ✓ sig. |
| protein localization to cell surface | GO:0034394 | 2 / 32 | 97.3× | 1.86e-4 | 4.82e-3 ✓ sig. |
| mesoderm formation | GO:0001707 | 2 / 38 | 82.0× | 2.62e-4 | 6.17e-3 ✓ sig. |
| transcription initiation-coupled chromatin remodeling | GO:0045815 | 2 / 41 | 76.0× | 3.06e-4 | 6.87e-3 ✓ sig. |
| regulation of neurogenesis | GO:0050767 | 2 / 49 | 63.6× | 4.37e-4 | 8.67e-3 ✓ sig. |
| thymus development | GO:0048538 | 2 / 50 | 62.3× | 4.55e-4 | 8.92e-3 ✓ sig. |
| odontogenesis of dentin-containing tooth | GO:0042475 | 2 / 56 | 55.6× | 5.71e-4 | 1.04e-2 ✓ sig. |
| glial cell fate determination | GO:0007403 | 1 / 1 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation | GO:0044338 | 1 / 1 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| lung cell differentiation | GO:0060479 | 1 / 1 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| cranial ganglion development | GO:0061550 | 1 / 1 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| regulation of membrane repolarization during atrial cardiac muscle cell action potential | GO:1905000 | 1 / 1 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |